Tissue-Engineered Injectable Collagen-Based Matrices for Improved Cell Delivery and Vascularization of Ischemic Tissue Using CD133+ Progenitors Expanded From the Peripheral Blood
Circulation - United States
doi 10.1161/circulationaha.105.001081
Full Text
Open PDFAbstract
Available in full text
Date
July 4, 2006
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)